Regulation and competition in pharmaceutical markets
Joan-Ramon Borrell (),
A. Costas Comesa-a and
R. Nonell Torres
Chapter 4 in The Public Financing of Pharmaceuticals, 2005 from Edward Elgar Publishing
This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.
Keywords: Economics and Finance (search for similar items in EconPapers)
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:3627_4
Ordering information: This item can be ordered from
Access Statistics for this chapter
More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().